Australian University Rankings Guide

American Annals of the Deaf (ERA Journal)

American Annals of the Deaf is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

American Annals of the Deaf issns are issn1: 0002-726X issn2: 0093-1284 issn3: 1543-0375.

The fields covered by American Annals of the Deaf as part of the evaluation of Australian university research excellence are:

Clinical Sciences Research Rankings (Sub-Field)

Specialist Studies In Education Research Rankings (Sub-Field)

Linguistics Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Clinical Sciences field include:

- American Journal of Speech-Language Pathology
- Blood Coagulation and Fibrinolysis: international journal in haemostasis and thrombosis
- Dementia: the international journal of social research and practice
- European Child and Adolescent Psychiatry: official journal of the European Society for Child and Adolescent Psychiatry
- Gene Expression Patterns
- International Journal of Disability Management Research
- International Journal of Speech-Language Pathology
- JAMA Internal Medicine
- Journal of Aging Research
- Journal of Gastroenterology and Hepatology
- Journal of Orthopaedics Trauma and Rehabilitation
- Logopedics Phoniatrics Vocology
- Nephrology Dialysis Transplantation
- Pathology Patterns Reviews
- Tumori: a journal of experimental and clinical oncology


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4